Integrating rapid syphilis and HIV testing for pregnant women could reduce maternal, child morbidity and mortality

NewsGuard 100/100 Score

"A study conducted in Uganda and Zambia by the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) found high rates of syphilis and HIV co-infection among pregnant women in both countries," but showed that "integrating rapid syphilis screening and HIV testing for pregnant women was feasible, cost-effective, and helped to prevent transmission of syphilis and HIV from mother-to-child," PlusNews reports.

"Like HIV, syphilis is a major cause of morbidity and mortality among women and children in developing countries," the news service writes, noting that the EGPAF study found that 14.3 percent of syphilis-positive pregnant women in Uganda also tested positive for HIV and 24.2 percent tested HIV-positive in Zambia. "The study's findings convinced Zambia's health ministry to include rapid syphilis testing in its standard package of PMCT [prevention of mother-to-child transmission] services and antenatal care, said Ministry of Health spokesperson, Reuben Kamoto Mbewe," PlusNews reports (9/1).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers receive NIH grant to help develop gene therapy for HIV